Supplementary Figure S3 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab Plus Tremelimumab in Resectable Head and Neck Squamous Cell CarcinomaChang Gon Kim,Min Hee Hong,Dahee Kim, Brian Hyohyoung Lee,Hyunwook Kim,Chan-Young Ock,Geoffrey Kelly,Yoon Ji Bang,Gamin Kim, Jung Eun Lee,Chaeyeon Kim,Se-Heon Kim,Hyun Jun Hong,Young Min Park,Nam Suk Sim,Heejung Park,Jin Woo Park,Chang Geol Lee,Kyung Hwan Kim,Goeun Park,Inkyung Jung,Dawoon Han,Jong Hoon Kim,Junha Cha,Insuk Lee,Mingu Kang,Heon Song,Chiyoon Oum, Seulki Kim,Sukjun Kim,Yoojoo Lim,Seunghee Kim-Schulze,Miriam Merad,Sun Och Yoon,Hyun Je Kim,Yoon Woo Koh,Hye Ryun Kimcrossref（2024）引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
